These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 24000082

  • 1. Thromboangiitis obliterans successfully treated with phosphodiesterase type 5 inhibitors.
    Abeles AM, Nicolescu M, Pinchover Z, Abeles M.
    Vascular; 2014 Aug; 22(4):313-6. PubMed ID: 24000082
    [Abstract] [Full Text] [Related]

  • 2. Treatment of thromboangiitis obliterans (Buerger's disease) with high-potency vasodilators.
    Jiménez-Gallo D, Albarrán-Planelles C, Arjona-Aguilera C, Blanco-Sánchez G, Rodríguez-Mateos ME, Linares-Barrios M.
    Dermatol Ther; 2015 Aug; 28(3):135-9. PubMed ID: 25649782
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Thromboangiitis obliterans (Buerger's disease).
    Olin JW, Shih A.
    Curr Opin Rheumatol; 2006 Jan; 18(1):18-24. PubMed ID: 16344615
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Thromboangiitis Obliterans (Buerger's Disease) in an Adolescent Male.
    Chapman S, Ballinger K, Chan MK, Stefanovici C, Rozovsky K, Boyd A, Vanan MI.
    J Pediatr Hematol Oncol; 2021 Aug 01; 43(6):e759-e762. PubMed ID: 32925405
    [Abstract] [Full Text] [Related]

  • 10. Buerger's disease (Thromboangiitis obliterans): a diagnostic challenge.
    Jorge VC, Araújo AC, Noronha C, Panarra A, Riso N, Vaz Riscado M.
    BMJ Case Rep; 2011 Sep 13; 2011():. PubMed ID: 22679237
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Thromboangiitis obliterans (Buerger's disease).
    Arkkila PE.
    Orphanet J Rare Dis; 2006 Apr 27; 1():14. PubMed ID: 16722538
    [Abstract] [Full Text] [Related]

  • 13. Thromboangiitis obliterans (Buerger's disease).
    Aqel MB, Olin JW.
    Vasc Med; 1997 Apr 27; 2(1):61-6. PubMed ID: 9546950
    [Abstract] [Full Text] [Related]

  • 14. An open-label study on long-term outcomes of bosentan for treating ulcers in thromboangiitis obliterans (Buerger's disease).
    De Haro J, Bleda S, Acin F.
    Int J Cardiol; 2014 Dec 15; 177(2):529-31. PubMed ID: 25217217
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [THROMBOANGIITIS OBLITERANS OVERLAPPING WITH ATHEROSCLEROTIC OCCLUSIVE ARTERIAL DISEASE: SMALL MESENTERIC ARTERY INVOLVEMENT BY THROMBOANGIITIS OBLITERANS].
    Rimar D, Rozenbaum M, Slobodin G, Boulman N, KaLy L, Rosner I.
    Harefuah; 2016 Jan 15; 155(1):41-4, 67, 66. PubMed ID: 27012074
    [Abstract] [Full Text] [Related]

  • 17. Thromboangiitis obliterans.
    Olin JW.
    Curr Opin Rheumatol; 1994 Jan 15; 6(1):44-9. PubMed ID: 7518238
    [Abstract] [Full Text] [Related]

  • 18. [Thromboangiitis obliterans (Buerger's disease): update 2015].
    Klein-Weigel P, Volz TS, Richter J.
    Dtsch Med Wochenschr; 2015 Oct 15; 140(20):1486-9. PubMed ID: 26445249
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of bosentan in digital ischemic ulcers.
    Todoli Parra JA, Hernández MM, Arrébola López MA.
    Ann Vasc Surg; 2010 Jul 15; 24(5):690.e1-4. PubMed ID: 20579585
    [Abstract] [Full Text] [Related]

  • 20. [A patient with thromboangiitis obliterans].
    Otterstad JE, Strøm O.
    Tidsskr Nor Laegeforen; 2002 Jan 20; 122(2):172-3. PubMed ID: 11873572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.